Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation
Bone Marrow Transplantation2011Vol. 47(4), pp. 528–534
Citations Over TimeTop 10% of 2011 papers
Syed W Bokhari, L. Watson, Sandeep Nagra, Mark Cook, Jenny Byrne, Charles Craddock, Nigel H. Russell
Related Papers
- → Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma(1994)45 cited
- → Factors influencing the chemosensitization of melphalan by misonidazole(1985)20 cited
- [Conservative therapy for retinoblastoma--effect of melphalan on in vitro electroretinogram].(1994)
- → Fludarabine plus cyclophosphamide combination: a new standard for first-line therapy in chronic lymphocytic leukaemiaa(2009)